明确非特异性:案例C-530/20 SIA“EUROAPTIEKA”

IF 1.8 Q1 LAW

European Journal of Risk Regulation Pub Date : 2023-07-28 DOI:10.1017/err.2023.55

Elijah Z. Granet

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Getting Specific on Non-Specificities: Case C-530/20 SIA “EUROAPTIEKA”

A pharmacy offering a discount on the bulk purchase of non-specified, non-prescription medicinal products was contrary to Directive 2003/83/EC, Articles 86 and 87, which applies to promotions for non-specified medicinal products (author ’ s summary)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Risk Regulation LAW-

CiteScore

6.10

自引率

0.00%

发文量

期刊介绍： European Journal of Risk Regulation is an interdisciplinary forum bringing together legal practitioners, academics, risk analysts and policymakers in a dialogue on how risks to individuals’ health, safety and the environment are regulated across policy domains globally. The journal’s wide scope encourages exploration of public health, safety and environmental aspects of pharmaceuticals, food and other consumer products alongside a wider interpretation of risk, which includes financial regulation, technology-related risks, natural disasters and terrorism.